Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Clinics ; 77: 100109, 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1404308

ABSTRACT

Abstract Objects: This study aimed to describe COVID-19 cases in healthcare workers at a large tertiary hospital, after a vaccination campaign, to understand the individual characteristics, timeliness, symptomatology, and severity of the conditions. Methods: The COVID-19 reporting files from the hospital's healthcare workers and their records in the vaccine registry were analyzed, regarding vaccination status, symptoms, sociodemographic characteristics, comorbidities, and outcomes. Vaccination descriptive analysis was carried out and the impact and effectiveness of vaccination in relation to symptomatic infection and hospitalization were estimated. Results: In a total of 696 PCR-confirmed COVID-19 patients, vaccination coverage for the 1st and 2nd dose was 92.8% and 85.5%. Patients with complete doses had a mean interval of 96.8 days between vaccination and the onset of symptoms. Of the 664 participants with available clinical data, 165 had at least 1 comorbidity. During the study, 12 patients were hospitalized, 58.3% with a complete vaccination schedule. Three of this group died. The effectiveness of vaccination for symptomatic cases and hospitalization was 22.1% and 69.0%, respectively. The impact of vaccination on symptomatic cases and hospitalization was 81.4% and 89.7%, respectively. Discussion: The majority of COVID-19 cases in the study were classified as mild. The impact of vaccination for confirmed cases was significant, both in reducing the incidence of symptomatic cases and hospitalizations. The presence of comorbidities in approximately » of the patients increased the risk of these individuals. The mean time interval between diagnosis and the 2nd dose of vaccine was longer in the hospitalized group, reinforcing the protective decline over longer periods.

2.
Mem. Inst. Oswaldo Cruz ; 112(1): 70-74, Jan. 2017. tab
Article in English | LILACS, SES-SP | ID: biblio-841755

ABSTRACT

With the urbanisation of the population in developing countries and the process of globalisation, Chagas has become an emerging disease in the urban areas of endemic and non-endemic countries. In 2006, it was estimated that the prevalence of Chagas disease among the general Bolivian population was 6.8%. The aim of the present study was to determine the prevalence of Trypanosoma cruzi infection among Bolivian immigrants living in São Paulo, Brazil. This study had a sample of 633 volunteers who were randomly selected from the clientele of primary care units located in the central districts of São Paulo, Brazil. Infection was detected by two different ELISA assays with epimastigote antigens, followed by an immunoblot with trypomastigote antigens as a confirmatory test. The prevalence of the infection was 4.4%. Risk factors independently associated with the infection were: a history of rural jobs in Bolivia, knowledge of the vector involved in transmission, and having relatives with Chagas disease. Brazil has successfully eliminated household vector transmission of T. cruzi, as well as its transmission by blood transfusion. The arrival of infected immigrants represents an additional challenge to primary care clinics to manage chronic Chagas disease, its vertical transmission, and the blood derivatives and organ transplant programs.


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Trypanosoma cruzi/immunology , Enzyme-Linked Immunosorbent Assay , Antibodies, Helminth/blood , Seroepidemiologic Studies , Chagas Disease/diagnosis , Chagas Disease/epidemiology , Emigrants and Immigrants/statistics & numerical data , Bolivia/ethnology , Brazil/epidemiology , Prevalence , Risk Factors
3.
Rev. bras. epidemiol ; 5(3): 229-243, dez. 2002.
Article in Portuguese | LILACS, BDS | ID: lil-334087

ABSTRACT

Discute a emergência do conceito de doenças infecciosas emergentes e reemergentes. Postula-se que o conceito surge frente às limitaçöes da teoria da transiçäo epidemiológica em explicar as tendências recentes da morbidade e as razöes de sua superaçäo. Em seguida, säo apresentados o conceito de doenças emergentes e reemergentes, os fatores relacionados à emergência das doenças infecciosas e as principais ocorrências no Brasil. Por fim, säo abordados os desafios colocados pela emergência e reemergência das doenças infecciosas, e propostas para o seu enfrentamento


Subject(s)
Epidemiology , Communicable Diseases , Brazil , Emergencies/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL